Navigation Links
Genzyme Announces Presentation of New Positive Data on Carticel(R)
Date:3/10/2008

nstruction prior to or concurrent with CARTICEL implantation.

Pre-existing conditions including meniscal tears, joint instability or malalignment of the joint should be corrected prior to or concurrent with CARTICEL implantation. It should not be used in patients with a known history of hypersensitivity to gentamicin, other aminoglycosides or materials of bovine origin. CARTICEL is not routinely tested for transmissible infectious diseases and may transmit disease to the healthcare provider handling CARTICEL. In addition, it should not be used in patients who have previously had cancer in the bones, cartilage, fat or muscle of the treated limb. Use in children, patients over age 65, or in joints other than the knee has not yet been assessed.

The occurrence of subsequent surgical procedures (SSPs), primarily after arthroscopy, following CARTICEL implantation is common. In the Study of the Treatment of Articular Repair (STAR), forty-nine percent (49%) of patients underwent an SSP on the treated knee, irrespective of their relationship to CARTICEL, during the 4-year follow-up. The most common serious adverse events (greater than or equal to 5% of patients), derived from STAR, include arthrofibrosis/joint adhesions, graft overgrowth, chondromalacia or chondrosis, cartilage injury, graft complication, meniscal lesion, graft delamination, and osteoarthritis. For more information about Carticel, visit http://www.carticel.com.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,500 employees in locations spanning the globe and 2006 revenues of $3.2 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the Unite
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
2. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
3. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
4. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Global ... World demand for caps and closures will exceed $55 ... to exceed two trillion annually. Beverages will continue to account ... pharmaceuticals and a number of smaller markets are expected to ... advances Although the most developed markets -- the US, ...
(Date:4/21/2015)... Fla. , April 21, 2015  A new, ... the First Coast that promises to revolutionize the way ... fellowship-trained at the world-renowned Montsouris Institute in ... guided prostate biopsy in the North Florida ... this innovative technology in prostate cancer diagnosis and management ...
(Date:4/21/2015)... Fla. , April 21, 2015   Rock ... drug development company focused on the treatment of chronic ... key independent appointment to the Company,s Board of Directors ... Samuel as a new director. ... of Rock Creek Pharmaceuticals, said, "Dr. Samuel,s experience in ...
Breaking Medicine Technology:World Caps & Closures Market 2World Caps & Closures Market 3Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 2Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 2Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 4Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 5Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 6Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 7
(Date:4/21/2015)... Point of Care Ultrasound is an ultrasound education company ... that will enable medics to perform and Stream live ... department or a consultant's smart device. Without taking valuable ... more advanced determinations will immediately be able to made ... or internal bleeding from trauma. , We will be ...
(Date:4/21/2015)... ID (PRWEB) April 21, 2015 My ... retailer to offer the latest innovation in home water ... ultra effective filtration system that makes existing gravity-fed filters ... Pro™ surpasses federal and industry standards for water filtration. ... daily supply for a typical household. , The Alexapure ...
(Date:4/21/2015)... Henry Mayo Newhall Hospital, located in California’s Santa ... automatically send continuation of care documents (CCDs). When the ... with clinics and other ambulatory practices, they selected Summit ... , “Provider Alert will enable the physician offices we ... to provide continuing care in real time,” said Cindy ...
(Date:4/21/2015)... Rockville, MD (PRWEB) April 21, 2015 ... half describe their child’s dental health as fair or ... Dentistry. This is not surprising, as a visit to ... with autism. The sensory overload from the strange smells, ... masked adult looming; and the unpredictability of the whole ...
(Date:4/21/2015)... Top medical tourism firm, VisitandCare.com, is recognizing a ... to providing superior patient experiences. Ojas Aesthetic Clinic ... best possible experience for a comprehensive range of treatments ... at Ojas Aesthetic Clinic persistently assert that, “Ojas Aesthetic ... you, without you — through transparent engagement with the ...
Breaking Medicine News(10 mins):Health News:Preparedness Leader My Patriot Supply Unveils the New Alexapure Pro™ Water Filter 2Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3
... senior authors are nationally known informatics leaders and members ... the Feb. 2010 issue of Health Affairs ... care delivery in an increasingly information-driven era of health ... critical role that information technology, and the health informatics ...
... metabolic events in bacteria that lead to fatal diseases such ... according to an article published in the February issue of ... Surrey are using this new ,systems biology, approach to try ... Mycobacterium tuberculosis which allow it to survive dormant ...
... be viable, researchers say , FRIDAY, Feb. 5 (HealthDay News) ... if they,re at risk of having children with spinal muscular ... controversy about whether screening for SMA -- the most common ... to couples. , In this study, researchers created an analytical ...
... 105 Million ... Alternative to Over-The-Counter Sleep Aids , ... Houston (PRWEB) February 5, 2010 -- Houston-based Aikon Wellness, Inc. announced today that it ... ). In a pre-market test, this natural sleep aid helped many people fall asleep ...
... ... the H1N1 influenza epidemic by facilitating easy transfer of health results to the Centers ... ... a leading provider of healthcare diagnostic information technology and outreach solutions, announced that its ...
... ... steady fixture in community well into its third decade of fighting for rights of Bucks ... Langhorne, Penn. ... Weber is celebrating its 25th anniversary of representing Bucks County residents in a wide ...
Cached Medicine News:Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 2Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 3Health News:Road mapping could be key to curing TB 2Health News:Screening for Spinal Muscular Atrophy Not Cost-Effective: Study 2Health News:Aikon Wellness Launches New Revolutionary All Natural Sleep Aid Somniac PM 2Health News:Aikon Wellness Launches New Revolutionary All Natural Sleep Aid Somniac PM 3Health News:Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results 2Health News:Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results 3Health News:Law Firm of Paul R. Weber Celebrates 25th Anniversary in Bucks County 2
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
Anterior Chamber Needle, 27 g., 5 mm from bend to tip. Overall length 22 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Straight with U-tip. U-shaped tip allows aspiration and irrigation at the 12 o'clock position. Overall length 18 mm. 5/box....
Medicine Products: